Lakefront Biotherapeutics | GLPG - Ebit





Ebit Cambio Fecha
argenx SE USD 394M 22.86M 2026-03
AstraZeneca USD 7.11B 4.14B 2026-03
Biogen USD 514.3M 502.8M 2026-03
Genmab DKK 260M 199M 2025-12
Gilead Sciences USD 2.68B 284M 2026-03
GlaxoSmithKline GBP 2.29B 856M 2026-03
GRIFOLS EUR 249M 103.11M 2026-03
Hikma Pharmaceutical USD 348M 31M 2025-12
Incyte USD 344.17M 39.71M 2026-03
Merck EUR 1.05B 572M 2026-03
Neurocrine Biosciences USD 214.6M 13.3M 2026-03
Novartis USD 4.18B 118M 2026-03
Roche Holding CHF 9.56B 2.1B 2025-12
Sanofi EUR 1.94B 239M 2026-03
UCB EUR 1.29B 571M 2025-12
Vertex Pharmaceuticals USD 1.14B 124.5M 2026-03